A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Phase 2CompletedNCT00242476

Merck Sharp & Dohme LLC216 enrolled

Overview

This study will assess the effectiveness of an investigational drug in elderly subjects with low vitamin D levels.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

216

Conditions

Vitamin D Deficiency

Interventions

MK0822ADRUG

Eligibility

Sex: ALLMin age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Man or a woman 70 years old or older in general good health Exclusion Criteria: * Having any form of neurological impairments that may impair motor function.

Outcomes

Primary Outcomes

Mediolateral body sway at 16 weeks.

Time frame: at 16 weeks

Secondary Outcomes

Functional status assessed using the Short Physical Performance Battery Test determined at 16 weeks. General safety and tolerability at 16 weeks.

Time frame: at 16 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.